Literature DB >> 23494651

A liquid chromatography-mass spectrometric method for the quantification of azithromycin in human plasma.

Mohamed Ben-Eltriki1, Vishwa Somayaji, Raj S Padwal, Dion R Brocks.   

Abstract

A liquid chromatographic mass spectrometric assay for the quantification of azithromycin in human plasma was developed. Azithromycin and imipramine (as internal standard, IS) were extracted from 0.5 mL human plasma using extraction with diethyl ether under alkaline conditions. Chromatographic separation of drug and IS was performed using a C18 column at room temperature. A mobile phase consisting of methanol, water, ammonium hydroxide and ammonium acetate was pumped at 0.2 mL/min. The mass spectrometer was operated in positive ion mode and selected ion recording acquisition mode. The ions utilized for quantification of azithromycin and IS were m/z 749.6 (M + H)(+) and m/z 591.4 (fragment) for azithromycin, and 281.1 m/z for internal standard; retention times were 6.9 and 3.4 min, respectively. The calibration curves were linear (r(2) > 0.999) in the concentration ranges of 10-1000 ng/mL. The mean absolute recoveries for 50 and 500 ng/mL azithromycin and 1 µg/ mL IS were >75%. The percentage coefficient of variation and mean error were <11%. Based on validation data, the lower limit of quantification was 10 ng/mL. The present method was successfully applied to determine azithromycin pharmacokinetic parameters in two obese volunteers. The assay had applicability for use in pharmacokinetic studies.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Human plasma; LC-MS; azithromycin; obese volunteers; pharmacokinetic study

Mesh:

Substances:

Year:  2013        PMID: 23494651     DOI: 10.1002/bmc.2896

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  3 in total

1.  Evaluation of the Microbiological Efficacy of a Single 2-Gram Dose of Extended-Release Azithromycin by Population Pharmacokinetics and Simulation in Japanese Patients with Gonococcal Urethritis.

Authors:  Midori Soda; Shin Ito; Naoki Matsumaru; Sakiko Nakamura; Izumi Nagase; Hikari Takahashi; Yuta Ohno; Mitsuru Yasuda; Miho Yamamoto; Katsura Tsukamoto; Yoshinori Itoh; Takashi Deguchi; Kiyoyuki Kitaichi
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Development and validation of an LC-MS/MS method for determination of hydroxychloroquine, its two metabolites, and azithromycin in EDTA-treated human plasma.

Authors:  Vong Sok; Florence Marzan; David Gingrich; Francesca Aweeka; Liusheng Huang
Journal:  PLoS One       Date:  2021-03-05       Impact factor: 3.240

3.  A simple, high-throughput and validated LC-MS/MS method for the determination of azithromycin in human plasma and its application to a clinical pharmacokinetic study.

Authors:  Yuning Zhang; Veenu Bala; Yashpal S Chhonker; Wafaa N Aldhafiri; Lucy N John; Catherine M Bjerum; Christopher L King; Oriol Mitja; Michael Marks; Daryl J Murry
Journal:  Biomed Chromatogr       Date:  2022-07-19       Impact factor: 1.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.